Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Protein kinase C beta in malignant pleural mesothelioma.
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Protein kinase C beta in malignant pleural mesothelioma.
Protein kinase C beta in malignant pleural mesothelioma. Anticancer Drugs. 2008 Oct; 19(9):841-8.
View in:
PubMed
subject areas
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cisplatin
Humans
Indoles
Inhibitory Concentration 50
Mesothelioma
Phorbol Esters
Phosphorylation
Pleural Neoplasms
Protein Kinase C
Protein Kinase C beta
Protein Kinase Inhibitors
Survival Rate
authors with profiles
Sivakumar Loganathan
Ravi Salgia
Hedy Kindler
Aliya Husain
Everett E. Vokes